MATRIX METALLOPROTEINASES AS PATHOGENETIC AND DIAGNOSTIC BIOMARKERS FOR SKIN SCARS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

To develop optimal treatments for skin scarring changes, it is necessary to understand the pathogenesis of the wound process that is a complex set of biological reactions.

Full Text

Restricted Access

About the authors

E. Luchlna

S.M. Kirov Military Medical Academy

Email: levistraus@mail.ru
Candidate of Medical Sciences

References

  1. Стенько А.Г., Круглова Л.С., Шматова А.А. и др. Консервативное лечение формирующихся рубцов: обзор современных технологий // Вестник эстетической медицины. - 2014; 13 (2): 42-50.
  2. Тарасенкова М.С., Юцковская Я.А., Наумчик Г.А. и др. Современные цметоды профилактики постоперационных патологических рубцов кожи // Эксперим. и клин. дерматокосметол. - 2010; 3: 50-4.
  3. Roh Y., Seo C., Jang K. Effects of a skin rehabilitation nursing program on skin status, depression, and burn-specific health in burn survivors // Rehabil. Nurs. - 2010; 35 (2): 65-9.
  4. Mamalis A., Jagdeo J. Light-emitting diode-generated red light inhibits keloid fibroblast proliferation // Dermatol. Surg. - 2015; 41 (1): 35-9.
  5. Wang A., Zhang W., Liang F. et al. Pre-expanded thoracodorsal artery perforator-based flaps for repair of severe scarring in cervicofacial regions // J. Reconstr. Microsurg. - 2014; 30 (8): 539-46.
  6. Gill S., Parks W. Metalloproteinases and their inhibitors: regulators of wound healing // Int. J. Biochem. Cell Biol. - 2008; 40: 1334-47.
  7. Герштейн Е.С., Левкина Н.В., Дигаева М.А. и др. Матриксные металлопротеиназы-2, -7, -9 и тканевой ингибитор металлопротеиназ 1-го типа в опухолях и сыворотке крови больных с новообразованиями яичников // Бюл. эксперим. биол. и медицины. - 2010; 149 (5): 562-5.
  8. Nissi R., Talvensaari-Mattila A., Kotila V. et al. Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure // Reprod. Biol. Endocrinol. - 2013; 15 (11): 2
  9. Cho S., Ryu D., Lee S. et al. Scar characteristics and treatment expectations: a survey of 589 patients // Cosmet. Laser Ther. - 2009; 11 (4): 224-8.
  10. Wagner W., Alfrink M., Micke O. Results of prophylactic irradiation in patients with resected keloids a retrospective analysis // Acta. Oncol. - 2000; 39 (2): 217-20.
  11. Марголина А.А., Эрнандес Е.И., Зайкина О.Э. Новая косметология / М.: Косметика и медицина, 2002; 208 с.
  12. Матыцин В.О., Михеева Н.В. Методы инструментальной диагностики и функционального состояния кожи // Натуральная фармакол. и косметол. -2005; 2: 35-7.
  13. Снарская Е.С. Комплексная терапия эстетических дефектов кожи в результате патологического фиброгенеза // Дерматология. Приложение к журналу Consilium Medicum. - 2013; 2-3: 15-20.
  14. Артыков К.П., Саидов М.С., Мухамадиева К.М. Влияние иммуномодулирующей терапии на результаты хирургической коррекции келлоидных рубцов кожи // Доклады Академии наук Республики Таджикистан. - 2014; 57 (2): 164-9.
  15. Chen J., Wang J., Zhuang H. Influence of substance P on the proliferation and apoptosis of fibroblasts of pathological scars // Zhonghua Shao Shang ZaZhi. - 2006; 22 (4): 277-80.
  16. Sauder D.N. Cutaneous immunobiology // Ann. Dermatol. Venereol. - 2002; 129: 274-83.
  17. Wolfram D., Tzankov A., Polzl P. et al. Hypertrophic scars and keloids. А review of their pathophysiology, risk factors, and therapeutic management // Dermatol. Surg. - 2009; 35: 171-81.
  18. Eto H., Suga H., Aoi N. et al. Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression // Lab. Invest. - 2012; 92: 214-23.
  19. Катунина А.И., Герштейн Е.С., Терешкина И.В. и др. Матриксные металлопротеиназы в опухолях больных раком молочной железы // Клин. лаб. диагностика. - 2010; 9: 27-7а.
  20. Ortak H., Demir S., Ateş Ö. et al. The role of MMP2 (-1306C>T) and TIMP2(-418G>C) promoter variants in age-related macular degeneration // Ophthalmic Genet. - 2013; 34 (4): 217-22.
  21. Imaizumi R., Akasaka Y., Inomata N. et al. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression // Histopathology. - 2009; 54: 722-30.
  22. Tandara A., Mustoe T. MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts - impact of coculture and hydration // J. Plast. Reconstr. Aesthet. Surg. - 2011; 64: 108-16.
  23. Ulrich D., Ulrich F., Unglaub F. et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids // J. Plast. Reconstr. Aesthet. Surg. - 2010; 63: 1015-21.
  24. Simon F., Bergeron D., Larochelle S. et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis // Burns. -2012; 38: 421-7.
  25. Taghiabadi E., Mohammadi P., Aghdami N. et al. Treatment of Hypertrophic Scar in Human with Autologous Transplantation of Cultured Keratinocytes and Fibroblasts along with Fibrin Glue // Cell J. - 2015; 17 (1): 49-58.
  26. Sadick H., Herberger A., Riedel K. et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts // Int. J. Mol. Med. - 2008; 22: 55-60.
  27. Fujiwara M., Muragaki Y., Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration // Br. J. Dermatol. - 2005; 153: 295300.
  28. Uchida G., Yoshimura K., Kitano Y. et al. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid derived fibroblasts // Exp. Dermatol. - 2003; 12 (Suppl. 2): 35-42.
  29. Chavez-Munoz C., Hartwell R., Jalili R. et al. Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model // J. Invest. Dermatol. - 2012; 132: 1501-5.
  30. Li Y., Kilani R., Rahmani-Neishaboor E. et al. Kynurenine increases matrix metalloproteinase-1 and -3 expression in cultured dermal fibroblasts and improves scarring in vivo // J. Invest. Dermatol. - 2014; 134: 643-50.
  31. Wei Y., Yan X., Ma L. et al. Oleanolic acid inhibits hypertrophic scarring in the rabbit ear model // Clin. Exp. Dermatol. - 2011; 36: 528-33.
  32. Kuo Y., Wu W., Jeng S. et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment // Lasers Surg. Med. - 2005; 36: 38-42.
  33. Rahmani-Neishaboor E., Yau F., Jalili R. et al. Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti-inflammatory factors in a rabbit ear model // Wound Repair Regen. - 2010; 18: 401-8.
  34. Djafarzadeh R., Conrad C., Notohamiprodjo S. et al. Cell surface engineering using glycosylphosphatidylinositol anchored tissue inhibitor of matrix metalloproteinase-1 stimulates cutaneous wound healing // Wound Repair Regen. - 2014; 22: 70-6.
  35. Stuart K., Paderi J., Snyder P. et al. Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring // PLoS One. -2011; 6: e22139.
  36. Ghahary A., Karimi-Busheri F., Marcoux Y. et al. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts // J. Invest. Dermatol. - 2004; 122: 1188-97.
  37. Rahmani-Neishaboor E., Jackson J., Burt H. et al. Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts // Pharm. Res. - 2009; 26: 002-2014.
  38. Lee W., Ahn H., Roh H. et al. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids // Exp. Dermatol. - 2015; 24 (8): 591-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies